Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	inf	0.00	75.08
Graham Fair Price	-1.94	77.67	79.21
PEG	154.21	-2.43	0.96
Price/Book	6.83	1.87	1.75
Price/Cash Flow	-60.25	14.44	36.32
Prices/Earnings	15.98	14.11	12.17
Price/Sales	1.24	15.81	15.62
Price/FCF	-60.25	14.44	36.32
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-59.10	1.00	2.44
Operating Margin	inf	0.00	0.47
ROA	-10.03	< 0.005	< 0.005
ROE	0.04	0.03	-7.89
ROIC	0.01	0.00	inf
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.06	0.25	-75.31
Dividends QOQ	0.56	0.05	-91.58
EBIT QOQ	411.81	-1.00	-99.76
EPS QOQ	0.10	-0.06	-42.67
FCF QOQ	0.36	1.75	390.02
Revenue QOQ	-0.58	0.08	-86.45
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	196.50	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.74	0.79	5.96
Quick Ratio	0.05	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	88.03	89.94	2.17
Cash	37.64	118.18	213.97
Capex	0.51	0.47	-6.42
Free Cash Flow	4.25	11.66	174.55
Revenue	9.88	10.65	7.81
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.05	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	39.83	0.00	inf
Naive Interpretation	Member

06 - Financial Health · Not Interpreted

Rating